HANSOH PHARMAC (Germany) Today
| 3KY Stock | EUR 1.97 0.05 2.48% |
Performance0 of 100
| Odds Of DistressLess than 9
|
HANSOH PHARMAC is trading at 1.97 as of the 8th of January 2025. This is a 2.48% down since the beginning of the trading day. The stock's lowest day price was 1.97. HANSOH PHARMAC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of January 2023 and ending today, the 8th of January 2025. Click here to learn more.
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the Peoples Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. The company has 5.92 B outstanding shares. More on HANSOH PHARMAC HD 00001
Moving against HANSOH Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HANSOH Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HANSOH PHARMAC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HANSOH PHARMAC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Huijuan Zhong |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
HANSOH PHARMAC HD 00001 (3KY) is traded on Frankfurt Exchange in Germany and employs 10,783 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HANSOH PHARMAC's market, we take the total number of its shares issued and multiply it by HANSOH PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HANSOH PHARMAC HD classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 5.92 B outstanding shares.
HANSOH PHARMAC HD 00001 has accumulated about 13.73 B in cash with 2.39 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check HANSOH PHARMAC Probability Of Bankruptcy
Ownership AllocationHANSOH PHARMAC HD 00001 has a total of 5.92 Billion outstanding shares. HANSOH PHARMAC HD retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.92 (percent) of HANSOH PHARMAC outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check HANSOH Ownership Details
HANSOH PHARMAC HD Risk Profiles
Although HANSOH PHARMAC's alpha and beta are two of the key measurements used to evaluate HANSOH PHARMAC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.37 | |||
| Standard Deviation | 3.76 | |||
| Variance | 14.17 | |||
| Risk Adjusted Performance | (0.05) |
HANSOH Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HANSOH PHARMAC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
HANSOH PHARMAC Corporate Management
Elected by the shareholders, the HANSOH PHARMAC's board of directors comprises two types of representatives: HANSOH PHARMAC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HANSOH. The board's role is to monitor HANSOH PHARMAC's management team and ensure that shareholders' interests are well served. HANSOH PHARMAC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HANSOH PHARMAC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Hu | Vice President | Profile | |
| Shengli Zhong | Vice President Joint Company Secretary | Profile | |
| Chuanhe Xu | Senior Vice President | Profile | |
| Sheung Chan | Non-Executive Independent Director | Profile | |
| Rudi Bao | Senior Vice President | Profile | |
| Chunhua Zhong | Senior Vice President | Profile |
Other Information on Investing in HANSOH Stock
HANSOH PHARMAC financial ratios help investors to determine whether HANSOH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HANSOH with respect to the benefits of owning HANSOH PHARMAC security.